1. Home
  2. TNDM vs ATRO Comparison

TNDM vs ATRO Comparison

Compare TNDM & ATRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNDM
  • ATRO
  • Stock Information
  • Founded
  • TNDM 2006
  • ATRO 1968
  • Country
  • TNDM United States
  • ATRO United States
  • Employees
  • TNDM N/A
  • ATRO N/A
  • Industry
  • TNDM Medical/Dental Instruments
  • ATRO Military/Government/Technical
  • Sector
  • TNDM Health Care
  • ATRO Industrials
  • Exchange
  • TNDM Nasdaq
  • ATRO Nasdaq
  • Market Cap
  • TNDM 1.1B
  • ATRO 1.2B
  • IPO Year
  • TNDM 2013
  • ATRO N/A
  • Fundamental
  • Price
  • TNDM $12.17
  • ATRO $40.28
  • Analyst Decision
  • TNDM Buy
  • ATRO Strong Buy
  • Analyst Count
  • TNDM 16
  • ATRO 1
  • Target Price
  • TNDM $23.50
  • ATRO $49.00
  • AVG Volume (30 Days)
  • TNDM 1.8M
  • ATRO 1.0M
  • Earning Date
  • TNDM 11-05-2025
  • ATRO 11-05-2025
  • Dividend Yield
  • TNDM N/A
  • ATRO N/A
  • EPS Growth
  • TNDM N/A
  • ATRO N/A
  • EPS
  • TNDM N/A
  • ATRO N/A
  • Revenue
  • TNDM $1,001,719,000.00
  • ATRO $822,852,000.00
  • Revenue This Year
  • TNDM $8.27
  • ATRO $9.05
  • Revenue Next Year
  • TNDM $9.72
  • ATRO $6.88
  • P/E Ratio
  • TNDM N/A
  • ATRO N/A
  • Revenue Growth
  • TNDM 25.84
  • ATRO 10.99
  • 52 Week Low
  • TNDM $9.98
  • ATRO $14.13
  • 52 Week High
  • TNDM $47.60
  • ATRO $46.61
  • Technical
  • Relative Strength Index (RSI)
  • TNDM 44.10
  • ATRO 59.53
  • Support Level
  • TNDM $12.10
  • ATRO $39.24
  • Resistance Level
  • TNDM $13.18
  • ATRO $46.61
  • Average True Range (ATR)
  • TNDM 0.59
  • ATRO 2.09
  • MACD
  • TNDM 0.21
  • ATRO 0.39
  • Stochastic Oscillator
  • TNDM 30.92
  • ATRO 41.34

About TNDM Tandem Diabetes Care Inc.

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless patch pump. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.

About ATRO Astronics Corporation

Astronics Corp supplies products to the aerospace, defense, and electronics industries. The company has two reportable segments namely Aerospace and Test Systems. The aerospace segment serves three primary markets: military, commercial transport, and General Aviation. The Test Systems segment serves the aerospace, defense, and semiconductor markets. The company generates a majority of its revenue from the Aerospace segment. Geographically, it generates a majority of its revenue from the United States.

Share on Social Networks: